Alberto Tosetto Selected Research

Antigens

1/2020	Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study.
8/2009	How I treat von Willebrand disease.
1/2009	Optimizing treatment of von Willebrand disease by using phenotypic and molecular data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Tosetto Research Topics

Disease

31	Hemorrhage 11/2022 - 03/2007
20	Venous Thromboembolism 03/2021 - 09/2002
9	Thrombosis (Thrombus) 01/2022 - 09/2002
5	von Willebrand Diseases (von Willebrand's Disease) 05/2022 - 05/2007
5	Essential Thrombocythemia 01/2022 - 09/2002
5	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 10/2003
4	Hemophilia A (Haemophilia) 02/2022 - 07/2019
4	Pulmonary Embolism 01/2016 - 10/2006
4	Type 1 von Willebrand Disease 04/2011 - 04/2008
3	Type 3 von Willebrand Disease 01/2022 - 01/2020
3	Neoplasms (Cancer) 01/2022 - 11/2009
3	Menorrhagia 12/2021 - 04/2011
3	Polycythemia Vera 01/2018 - 09/2002
3	Thrombophilia 03/2012 - 09/2002
2	Inflammation (Inflammations) 01/2022 - 10/2012
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021 - 01/2018
2	Atrial Fibrillation 01/2018 - 08/2011
2	Atherosclerosis 01/2018 - 02/2011
2	Stroke (Strokes) 01/2015 - 08/2011
1	Infections 01/2022
1	Varicose Veins (Varicose Vein) 10/2020
1	Epistaxis (Nosebleed) 01/2020
1	Hemarthrosis 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Myocardial Infarction 01/2018
1	Ischemic Stroke 01/2018
1	Type 2 von Willebrand Disease 02/2015
1	Renal Insufficiency (Renal Failure) 01/2015
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2012
1	Spontaneous Abortion (Miscarriage) 03/2012
1	Pulmonary Hypertension 02/2012
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 02/2012
1	Obesity 06/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2010
1	Hypertension (High Blood Pressure) 06/2010
1	Autoimmune Diseases (Autoimmune Disease) 06/2010
1	Vascular Diseases (Vascular Disease) 06/2010
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2010
1	Thromboembolism 10/2006
1	Multiple Myeloma 06/2006

Drug/Important Bio-Agent (IBA)

13	von Willebrand FactorIBA 05/2022 - 05/2007
11	fibrin fragment D (D-dimer)IBA 01/2016 - 10/2006
9	Vitamin K FDA Link 01/2022 - 10/2006
9	Factor VIII (Coagulation Factor VIII)IBA 12/2021 - 08/2004
9	AnticoagulantsIBA 12/2021 - 09/2002
5	Hemostatics (Antihemorrhagics)IBA 02/2022 - 02/2015
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 03/2012
4	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 12/2021 - 04/2008
4	Biomarkers (Surrogate Marker)IBA 01/2013 - 04/2008
3	RivaroxabanIBA 01/2022 - 01/2018
3	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2018
3	AntigensIBA 01/2020 - 01/2009
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020 - 03/2012
3	SuspensionsIBA 07/2017 - 01/2010
3	factor V LeidenIBA 03/2012 - 09/2002
3	Factor V (Coagulation Factor V)IBA 08/2004 - 09/2002
2	Tranexamic Acid (AMCA)FDA Link 11/2022 - 04/2011
2	recombinant factor VIII N8IBA 02/2022 - 05/2020
2	C-Reactive ProteinIBA 10/2012 - 02/2011
2	Fibrinogen (Factor I)FDA Link 10/2012 - 02/2011
2	Prothrombin (Factor II)IBA 03/2012 - 08/2004
2	Biological ProductsIBA 06/2010 - 04/2008
2	Fumigant 93 (D-D)IBA 01/2010 - 11/2009
2	Protein CIBA 08/2004 - 09/2002
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	ThromboxanesIBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2021
1	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 03/2021
1	GlycosaminoglycansIBA 03/2021
1	Dabigatran FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	emicizumabIBA 01/2020
1	insulin receptor-related receptor (IRR)IBA 11/2019
1	Thromboxane B2IBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	CreatinineIBA 01/2015
1	Inosine Triphosphate (ITP)IBA 04/2013
1	SmogIBA 04/2013
1	CholesterolIBA 10/2012
1	HDL CholesterolIBA 10/2012
1	Blood Group Antigens (Blood Groups)IBA 04/2011
1	IronIBA 04/2011
1	Combined Oral ContraceptivesIBA 04/2011
1	Hormones (Hormone)IBA 02/2011
1	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2010
1	von Willebrand factor drug combination factor VIIIIBA 06/2010
1	asialo-von Willebrand FactorIBA 08/2009
1	Biological FactorsIBA 03/2007
1	Melphalan (Alkeran)FDA LinkGeneric 06/2006

Therapy/Procedure

10	Therapeutics 01/2022 - 10/2010
2	Minor Surgical Procedures (Minor Surgery) 12/2021 - 05/2020
1	Anesthesia 12/2021
1	Bed Rest (Bedrest) 10/2020
1	Surgical Casts (Plaster Cast) 10/2020
1	Tooth Extraction (Tooth Extractions) 01/2020
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2017
1	Operative Surgical Procedures 01/2008
1	Stem Cell Transplantation 06/2006